- Home
- VERB vs IBO Comparison
VERB vs IBO Comparison
Compare VERB & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERB
- IBO
- Stock Information
- Founded
- VERB 2014
- IBO 2018
- Country
- VERB United States
- IBO United States
- Employees
- VERB N/A
- IBO N/A
- Industry
- VERB Other Consumer Services
- IBO
- Sector
- VERB Consumer Discretionary
- IBO
- Exchange
- VERB Nasdaq
- IBO NYSE
- Market Cap
- VERB 5.8M
- IBO 5.1M
- IPO Year
- VERB N/A
- IBO 2024
- Fundamental
- Price
- VERB $8.98
- IBO $0.47
- Analyst Decision
- VERB Strong Buy
- IBO
- Analyst Count
- VERB 1
- IBO 0
- Target Price
- VERB $62.00
- IBO N/A
- AVG Volume (30 Days)
- VERB 111.1K
- IBO 505.3K
- Earning Date
- VERB 05-13-2025
- IBO 06-13-2025
- Dividend Yield
- VERB N/A
- IBO N/A
- EPS Growth
- VERB N/A
- IBO N/A
- EPS
- VERB N/A
- IBO N/A
- Revenue
- VERB $2,193,000.00
- IBO N/A
- Revenue This Year
- VERB $287.49
- IBO N/A
- Revenue Next Year
- VERB $47.06
- IBO N/A
- P/E Ratio
- VERB N/A
- IBO N/A
- Revenue Growth
- VERB 3125.00
- IBO N/A
- 52 Week Low
- VERB $3.81
- IBO $0.37
- 52 Week High
- VERB $30.98
- IBO $6.17
- Technical
- Relative Strength Index (RSI)
- VERB 73.50
- IBO N/A
- Support Level
- VERB $5.94
- IBO N/A
- Resistance Level
- VERB $8.49
- IBO N/A
- Average True Range (ATR)
- VERB 0.67
- IBO 0.00
- MACD
- VERB 0.23
- IBO 0.00
- Stochastic Oscillator
- VERB 83.31
- IBO 0.00
About VERB Verb Technology Company Inc.
Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.